NCT00464074 Evaluation of Natalizumab for thE Relief of MS Associated FatiGue Status COMPLETED Phase N/A
NCT00463710 Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS Status COMPLETED Phase N/A
NCT00461396 Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron Status COMPLETED Phase N/A
NCT00457730 A Study to Test the Use of Duloxetine for Pain in MS Status COMPLETED Phase PHASE2/PHASE3
NCT00439257 Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron) Status COMPLETED Phase N/A
NCT00436826 A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD) Status COMPLETED Phase PHASE2
NCT00432900 Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT00430599 The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis Status COMPLETED Phase N/A
NCT00423111 Correlation Between Cognitive Functions and MRI in Multiple Sclerosis Status UNKNOWN Phase N/A
NCT00418145 Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks Status TERMINATED Phase PHASE3
NCT00414453 Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis Status TERMINATED Phase PHASE4
NCT00395317 Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS) Status COMPLETED Phase PHASE2
NCT00395200 Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) Status COMPLETED Phase PHASE1/PHASE2
NCT00393588 Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis Status COMPLETED Phase N/A